From: Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
Predictors | Â | Death during treatment N (%) | Unadjusted HR (95% CI), p value | Adjusted HR (95% CI), p value |
---|---|---|---|---|
N | Â | 37 | Â | Â |
Mean age at diagnosis ± SD (hazard/10 year increase) |  | 45 ± 16 | 1.26 (1.03-1.55), 0.03 | 1.52 (1.18-1.95), 0.001 |
Gender | Male | 29 (6.4) | 0.98 (0.44-2.14), 0.95 | Â |
 | Female | 8 (7.1) |  |  |
Ethnicity | Hispanic | 7 (4.2) | 0.55 (0.24-1.27), 0.16 | Â |
 | Non-Hispanic | 30 (7.5) |  |  |
Place of birth | U.S. | 31 (7.9) | 2.92 (1.10-7.74), 0.03 | 2.70 (0.96-7.63), 0.06 |
 | Foreign | 6 (3.5) |  |  |
HIV status | Positive | 24 (11.8) | 2.30 (1.14-4.61), 0.02 | 2.57 (1.17-5.64), 0.02 |
 | Negative/Unknown | 13 (3.6) |  |  |
DOT1 | Yes/Partial* | 32/373 (8.6) | 2.65 (1.02-6.87), 0.04 | 1.31 (0.47-3.64), 0.61 |
 | No | 5/190 (2.6) |  |  |
Episode of inadequate therapy during intensive phase2 | Yes | 24/153 (15.7) | 3.39 (1.68-6.83), 0.001 | 3.15 (1.52-6.52), 0.002 |
 | No | 13/409 (3.2) |  |  |
Episode of inadequate therapy during continuation phase3 | Yes | 10/126 (7.9) | 0.72 (0.32-1.65), 0.44 | Â |
 | No | 23/430 (5.4) |  |  |
Sputum smear status | Positive | 27 (10.4) | 2.97 (1.43-6.17), 0.004 | 3.07 (1.44-6.56), 0.004 |
 | Negative | 10 (3.3) |  |  |
Extrapulmonary in addition to pulmonary | Yes | 18 (11.2) | 1.69 (0.85-3.34), 0.13 | Â |
 | No | 19 (4.7) |  |  |
Cavitary disease | Yes | 4 (3.0) | 0.43 (0.15-1.23), 0.12 | Â |
 | No | 33 (7.6) |  |  |
Any prior medical condition | Yes | 25 (8.0) | 1.74 (0.85-3.54), 0.13 | Â |
 | No | 12 (4.8) |  |  |